Halozyme Therapeutics net change in short-term investments for the twelve months ending March 31, 2025 was $-1.056B, a 146.91% increase year-over-year.
Halozyme Therapeutics annual net change in short-term investments for 2024 was $-0.252B, a 208.8% increase from 2023.
Halozyme Therapeutics annual net change in short-term investments for 2023 was $-0.082B, a 116.62% decline from 2022.
Halozyme Therapeutics annual net change in short-term investments for 2022 was $0.491B, a 221.26% decline from 2021.
Halozyme Therapeutics Net Change in Short-term Investments 2010-2025 | HALO